IL-25 enhances T<sub>H</sub>17 cell-mediated contact dermatitis by promoting IL-1β production by dermal dendritic cells.
Where this comes from
- Record sourced from PubMed, PMID 29522843.
- Also identified by DOI 10.1016/j.jaci.2017.12.1007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In addition to thymic stromal lymphopoietin and IL-33, IL-25 is known to induce T<sub>H</sub>2 cytokine production by various cell types, including T<sub>H</sub>2 cells, T<sub>H</sub>9 cells, invariant natural killer T cells, and group 2 innate lymphoid cells, involved in T<sub>H</sub>2-type immune responses. Because both T<sub>H</sub>2-type and T<sub>H</sub>17-type cells/cytokines are crucial for contact hypersensitivity (CHS), IL-25 can contribute to this by enhancing T<sub>H</sub>2-type immune responses. However, the precise role of IL-25 in the pathogenesis of fluorescein isothiocyanate-induced CHS is poorly understood. We investigated the contribution of IL-25 to CHS using Il25<sup>-/-</sup> mice. CHS was evaluated by means of measurement of ear skin thickness in mice after fluorescein isothiocyanate painting. Skin dendritic cell (DC) migration, hapten-specific T<sub>H</sub> cell differentiation, and detection of IL-1β-producing cells were determined by using flow cytometry, ELISA, and immunohistochemistry, respectively. In contrast to thymic stromal lymphopoietin, we found that IL-25 was not essential for skin DC migration or hapten-specific T<sub>H</sub> cell differentiation in the sensitization phase of CHS. Unexpectedly, mast cell- and non-immune cell-derived IL-25 was important for hapten-specific T<sub>H</sub>17 cell-mediated rather than T<sub>H</sub>2 cell-mediated inflammation in the elicitation phase of CHS by enhancing T<sub>H</sub>17-related, but not T<sub>H</sub>2-related, cytokines in the skin. In particular, IL-1β produced by dermal DCs in response to IL-25 was crucial for hapten-specific T<sub>H</sub>17 cell activation, contributing to induction of local inflammation in the elicitation phase of CHS. Our results identify a novel IL-25 inflammatory pathway involved in induction of T<sub>H</sub>17 cell-mediated, but not T<sub>H</sub>2 cell-mediated, CHS. IL-25 neutralization can be a potential approach for treatment of CHS.
Medical subject headings
- Cytokines
- Dermatitis, Allergic Contact
- Th17 Cells